These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33835351)

  • 21. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games.
    Stuart M; Kwon YI; Rhie SJ
    Br J Sports Med; 2019 Sep; 53(17):1105-1110. PubMed ID: 30894336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and factor analysis for the heat-related illness on the Tokyo 2020 Olympic and Paralympic Games.
    Inoue H; Tanaka H; Sakanashi S; Kinoshi T; Numata H; Yokota H; Otomo Y; Masuno T; Nakano K; Sugita M; Tokunaga T; Sugimoto K; Inoue J; Kato N; Nakagawa K; Tanaka S; Sagisaka R; Miyamoto T; Akama T
    BMJ Open Sport Exerc Med; 2023; 9(2):e001467. PubMed ID: 37051574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nationalistic Media Obsession With Olympic Medal Counts: The Case of the 2020 Tokyo Olympic Games.
    Dittmore S; Kim K
    Front Sports Act Living; 2022; 4():848071. PubMed ID: 35359503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief History of Anti-Doping.
    Ljungqvist A
    Med Sport Sci; 2017; 62():1-10. PubMed ID: 28571021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical progresses of the World Anti-Doping Agency Olympic laboratories: a 2016 update from London to Rio.
    Athanasiadou I; Voss S; Lyris E; Aljaber A; Alsayrafi M; Georgakopoulos C
    Bioanalysis; 2016 Nov; 8(21):2265-2279. PubMed ID: 27665839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population Muscle Strength Predicts Olympic Medal Tallies: Evidence from 20 Countries in the PURE Prospective Cohort Study.
    Leong DP; McKee M; Yusuf S;
    PLoS One; 2017; 12(1):e0169821. PubMed ID: 28107362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Career factors related to winning Olympic medals in swimming.
    Tchamkerten A; Chaudron P; Girard N; Monnier A; Pyne DB; Hellard P
    PLoS One; 2024; 19(6):e0304444. PubMed ID: 38941281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. World Championship and Olympic Games Experience Influences Future Medal Performance in Track-and-Field Athletes.
    Fulton TJ; Baranauskas MN; Chapman RF
    Int J Sports Physiol Perform; 2022 Jan; 17(1):111-114. PubMed ID: 34174783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
    Georgakopoulos C; Saugy M; Giraud S; Robinson N; Alsayrafi M
    Bioanalysis; 2012 Jul; 4(13):1549-63. PubMed ID: 22831472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cadet and Junior Performance Is Associated With Senior's World Championship and Olympics Achievement in Judo.
    Junior MN; Lopes-Silva JP; Takito MY; Franchini E
    Res Q Exerc Sport; 2024 Mar; 95(1):54-59. PubMed ID: 36693247
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012.
    Fitch KD
    Br J Sports Med; 2013 Sep; 47(13):815-8. PubMed ID: 23591601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interview: partnering with the industry: the Olympic laboratory model.
    Cowan DA; Barker CP
    Bioanalysis; 2012 Jul; 4(13):1545-8. PubMed ID: 22831471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. World anti-doping regulations for 2005: essential changes for athletes and physicians.
    Pabinger C; Gruber G
    Arch Orthop Trauma Surg; 2006 May; 126(4):286-8. PubMed ID: 16333634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Medal in the Olympics Runs in the Family: A Cohort Study of Performance Heritability in the Games History.
    Antero J; Saulière G; Marck A; Toussaint JF
    Front Physiol; 2018; 9():1313. PubMed ID: 30283357
    [No Abstract]   [Full Text] [Related]  

  • 36. Competitive performance as a discriminator of doping status in elite athletes.
    Hopker JG; Griffin JE; Hinoveanu LC; Saugy J; Faiss R
    Drug Test Anal; 2024 May; 16(5):473-481. PubMed ID: 37602904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of doping in Flanders in comparison to the prevalence of doping in international sports.
    Van Eenoo P; Delbeke FT
    Int J Sports Med; 2003 Nov; 24(8):565-70. PubMed ID: 14598191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008].
    Thevis M; Hemmersbach P; Geyer H; Schänzer W
    Med Klin (Munich); 2009 Dec; 104(12):918-24. PubMed ID: 20039158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use and abuse of anabolic steroids in Olympic-caliber athletes.
    Bergman R; Leach RE
    Clin Orthop Relat Res; 1985 Sep; (198):169-72. PubMed ID: 4028547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication use by athletes at the Athens 2004 Summer Olympic Games.
    Tsitsimpikou C; Tsiokanos A; Tsarouhas K; Schamasch P; Fitch KD; Valasiadis D; Jamurtas A
    Clin J Sport Med; 2009 Jan; 19(1):33-8. PubMed ID: 19124981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.